We’re In! GelSana Therapeutics, Inc. Joins the 2025 MedTech Innovator Cohort We’re proud to share that GelSana Therapeutics, Inc. has been selected to join the 2025 MedTech Innovator cohort, the world’s largest accelerator for medical device companies. GelSana is one of…
Melissa Krebs, CEO, has been inducted into the American Institute for Medical and Biological Engineering College of Fellows. AIMBE membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new…
GelSana is proud to announce that we have been awarded another NIH SBIR Phase I funding through the NIDDK for the development of a polymer designed for the sustained delivery of a therapeutic growth factor to treat diabetic foot ulcers.…
GelSana, an Innosphere Ventures client company, today announced that Diana Verrilli, Chief Growth Officer at DispatchHealth, will join the Company’s Board of Directors. Diana, an accomplished healthcare leader brings extensive experience in commercialization and business strategy planning and execution. “GelSana is very…
(AURORA, CO) – May 7, 2024 – GelSana, an Innosphere Ventures client company, today announced it has hired Jon Fernandez as Chief Operation Officer. Jon brings a wealth of experience in both product development, including in wound healing, as well as…
(AURORA, CO) – April 10, 2024 – GelSana announces it has been selected by AFWERX for a Phase II SBIR contract in the amount of $1.25M focused on novel polymers for enhanced wound healing of burns addressing one of the most…
(GOLDEN, CO) – February 19, 2024 – GelSana Therapeutics, a Colorado-based biomaterials company founded by Colorado School of Mines professor Melissa Krebs, has received its first investment from the Mines Venture Fund I. This fund targets startups led by Colorado…
Thrilled to announce the initial close on our second Seed fundraising round for GelSana! Innosphere Ventures Fund is leading the round and we are so appreciative of their continued support, along with the support of our other investors. Fort…
GelSana was honored to be selected as one of the startups to present at the 2023 Silicon Valley Leaders Forum HealthTech Showcase, sponsored by the American Diabetes Association. It was inspiring to be recognized as one of the companies leading…
GelSana was selected as one of the companies to pitch at Fitzsimons Innovation Community Media Pitch Day in October 2023. “With Aimco, Fitzsimons Innovation Community hosted members of the local and national media. They learned firsthand about breakthrough work from…
